These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 39123399)
1. Advancements in Research and Treatment Applications of Patient-Derived Tumor Organoids in Colorectal Cancer. van der Graaff D; Seghers S; Vanclooster P; Deben C; Vandamme T; Prenen H Cancers (Basel); 2024 Jul; 16(15):. PubMed ID: 39123399 [TBL] [Abstract][Full Text] [Related]
2. Patient-Derived Tumor Organoids for Drug Repositioning in Cancer Care: A Promising Approach in the Era of Tailored Treatment. Vivarelli S; Candido S; Caruso G; Falzone L; Libra M Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33291603 [TBL] [Abstract][Full Text] [Related]
3. Tumour organoids and assembloids: Patient-derived cancer avatars for immunotherapy. Mei J; Liu X; Tian HX; Chen Y; Cao Y; Zeng J; Liu YC; Chen Y; Gao Y; Yin JY; Wang PY Clin Transl Med; 2024 Apr; 14(4):e1656. PubMed ID: 38664597 [TBL] [Abstract][Full Text] [Related]
5. Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology. Thorel L; Perréard M; Florent R; Divoux J; Coffy S; Vincent A; Gaggioli C; Guasch G; Gidrol X; Weiswald LB; Poulain L Exp Mol Med; 2024 Jul; 56(7):1531-1551. PubMed ID: 38945959 [TBL] [Abstract][Full Text] [Related]
7. Comparison of Cell and Organoid-Level Analysis of Patient-Derived 3D Organoids to Evaluate Tumor Cell Growth Dynamics and Drug Response. Kim S; Choung S; Sun RX; Ung N; Hashemi N; Fong EJ; Lau R; Spiller E; Gasho J; Foo J; Mumenthaler SM SLAS Discov; 2020 Aug; 25(7):744-754. PubMed ID: 32349587 [TBL] [Abstract][Full Text] [Related]
8. Organoids as a Robust Preclinical Model for Precision Medicine in Colorectal Cancer: A Systematic Review. Flood M; Narasimhan V; Wilson K; Lim WM; Ramsay R; Michael M; Heriot A Ann Surg Oncol; 2022 Jan; 29(1):47-59. PubMed ID: 34596795 [TBL] [Abstract][Full Text] [Related]
9. Exploring Tumor-Immune Interactions in Co-Culture Models of T Cells and Tumor Organoids Derived from Patients. Jeong SR; Kang M Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834057 [TBL] [Abstract][Full Text] [Related]
10. Validation of a Novel EUS-FNB-Derived Organoid Co-Culture System for Drug Screening in Patients with Pancreatic Cancer. Grützmeier SE; Kovacevic B; Vilmann P; Rift CV; Melchior LC; Holmström MO; Brink L; Hassan H; Karstensen JG; Grossjohann H; Chiranth D; Toxværd A; Hansen CP; Høgdall E; Hasselby JP; Klausen P Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509338 [TBL] [Abstract][Full Text] [Related]
11. Unveiling the functional roles of patient-derived tumour organoids in assessing the tumour microenvironment and immunotherapy. Chen D; Xu L; Xuan M; Chu Q; Xue C Clin Transl Med; 2024 Sep; 14(9):e1802. PubMed ID: 39245957 [TBL] [Abstract][Full Text] [Related]
12. CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes. Takeda H; Kataoka S; Nakayama M; Ali MAE; Oshima H; Yamamoto D; Park JW; Takegami Y; An T; Jenkins NA; Copeland NG; Oshima M Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15635-15644. PubMed ID: 31300537 [TBL] [Abstract][Full Text] [Related]
13. Protocol for generation of and high-throughput drug testing with patient-derived colorectal cancer organoids. Tan T; Mouradov D; Gibbs P; Sieber OM STAR Protoc; 2024 Jun; 5(2):103090. PubMed ID: 38809757 [TBL] [Abstract][Full Text] [Related]
14. Epidermal Growth Factor Receptor Targeting in Colorectal Carcinoma: Antibodies and Patient-Derived Organoids as a Smart Model to Study Therapy Resistance. Tardito S; Matis S; Zocchi MR; Benelli R; Poggi A Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000238 [TBL] [Abstract][Full Text] [Related]
15. Next generation patient derived tumor organoids. Podaza E; Kuo HH; Nguyen J; Elemento O; Martin ML Transl Res; 2022 Dec; 250():84-97. PubMed ID: 35964899 [TBL] [Abstract][Full Text] [Related]
16. Deciphering the Tumor Microenvironment of Colorectal Cancer and Guiding Clinical Treatment With Patient-Derived Organoid Technology: Progress and Challenges. Li J; Liu J; Xia W; Yang H; Sha W; Chen H Technol Cancer Res Treat; 2024; 23():15330338231221856. PubMed ID: 38225190 [TBL] [Abstract][Full Text] [Related]
17. The landscape of drug sensitivity and resistance in sarcoma. Al Shihabi A; Tebon PJ; Nguyen HTL; Chantharasamee J; Sartini S; Davarifar A; Jensen AY; Diaz-Infante M; Cox H; Gonzalez AE; Swearingen S; Tavanaie N; Dry S; Singh A; Chmielowski B; Crompton JG; Kalbasi A; Eilber FC; Hornicek F; Bernthal N; Nelson SD; Boutros PC; Federman N; Yanagawa J; Soragni A bioRxiv; 2023 Aug; ():. PubMed ID: 37292676 [TBL] [Abstract][Full Text] [Related]
18. Culture of patient-derived multicellular clusters in suspended hydrogel capsules for pre-clinical personalized drug screening. Dong H; Li Z; Bian S; Song G; Song W; Zhang M; Xie H; Zheng S; Yang X; Li T; Song P Bioact Mater; 2022 Dec; 18():164-177. PubMed ID: 35387168 [TBL] [Abstract][Full Text] [Related]
19. Three-Dimensional Organoids in Cancer Research: The Search for the Holy Grail of Preclinical Cancer Modeling. Dzobo K; Rowe A; Senthebane DA; AlMazyadi MAM; Patten V; Parker MI OMICS; 2018 Dec; 22(12):733-748. PubMed ID: 30571609 [TBL] [Abstract][Full Text] [Related]
20. Hydrogel-based colorectal cancer organoid co-culture models. Luo X; Fong ELS; Zhu C; Lin QXX; Xiong M; Li A; Li T; Benoukraf T; Yu H; Liu S Acta Biomater; 2021 Sep; 132():461-472. PubMed ID: 33388439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]